Account
Inquiry
Peptide Pros presents premium quality Mazdutide/Cagrilintide lyophilized powder therapy kits (CAS 2381089-83-2) for research purposes. This innovative triple agonist peptide, also known as Retatrutide or LY3437943, demonstrates exceptional activity against glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).
The product shows remarkable inhibitory effects with EC50 values of 5.79 nM for human GCGR, 0.0643 nM for GIPR, and 0.775 nM for GLP-1R respectively. These characteristics make it particularly valuable for obesity-related research applications.
Key research applications include: glucose metabolism regulation, appetite suppression, weight management studies, and metabolic syndrome research. The peptide has demonstrated potential in slowing gastric emptying, reducing hepatic glucose production, and enhancing pancreatic insulin secretion in response to elevated blood sugar levels.
For research storage, maintain in tightly sealed, light-resistant containers at controlled room temperature. Avoid exposure to direct sunlight, moisture and excessive heat to preserve stability. Under proper storage conditions, the product maintains optimal performance for 24 months.
Available in multiple research-grade quantities with purity exceeding 99%. The lyophilized powder formulation ensures maximum stability and convenient reconstitution for experimental use. All batches undergo rigorous quality control testing to guarantee consistency and performance in research settings.
Important Note: This product is intended for research use only by qualified professionals. Not for human consumption or diagnostic use. Proper laboratory safety protocols should always be followed when handling this material.
